Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Neurocrine Phase II insomnia data

NBIX said that in a double-blind, placebo-controlled U.S. Phase II study in 79 patients (ages 65-75)

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE